Compare Nomura Holdings Inc (NMR) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs Summit Therapeutics Inc — how do they compare? Nomura Holdings Inc trades at $9.4 (market cap $27.46B), while Summit Therapeutics Inc trades at $14.58 (market cap $10.48B). The key difference: Nomura Holdings Inc is far larger — about 2.6× Summit Therapeutics Inc's market cap, and Nomura Holdings Inc pays a 3.45% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NMR | SMMT | |
|---|---|---|
Market Cap | $27.46B | $10.48B |
Sector | Financials | Health |
52-Week High | $10.04 | $29.32 |
52-Week Low | $6.39 | $13.05 |
Dividend Yield | 3.45% | — |
Enterprise Value | — | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
